A detailed history of State Street Corp transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, State Street Corp holds 71,408 shares of GLSI stock, worth $921,163. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,408
Previous 68,403 4.39%
Holding current value
$921,163
Previous $1.18 Million 13.05%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$12.99 - $17.58 $39,034 - $52,827
3,005 Added 4.39%
71,408 $1.03 Million
Q2 2024

Aug 14, 2024

BUY
$12.07 - $19.04 $668,690 - $1.05 Million
55,401 Added 426.1%
68,403 $1.18 Million
Q2 2022

Aug 15, 2022

SELL
$7.14 - $20.36 $381,868 - $1.09 Million
-53,483 Reduced 80.44%
13,002 $110,000
Q1 2022

May 16, 2022

BUY
$16.3 - $24.65 $19,168 - $28,988
1,176 Added 1.8%
66,485 $1.3 Million
Q4 2021

Feb 14, 2022

BUY
$21.76 - $39.43 $121,747 - $220,610
5,595 Added 9.37%
65,309 $1.59 Million
Q3 2021

Nov 15, 2021

BUY
$38.65 - $46.11 $367,252 - $438,137
9,502 Added 18.92%
59,714 $2.33 Million
Q2 2021

Aug 16, 2021

BUY
$31.24 - $53.6 $1.57 Million - $2.69 Million
50,212 New
50,212 $2.26 Million

Others Institutions Holding GLSI

About Greenwich LifeSciences, Inc.


  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $166M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.